Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Clinical trial NCT07148128 · RECRUITING

Trial details

NCT number: NCT07148128
Sponsor: Auricula Biosciences Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer Advanced Solid Tumors Advanced or Metastatic KRAS-mutant Tumor

Start date: 2025-07-28
Primary completion: 2028-01-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.